How to Get Semaglutide Covered by Insurance: 7 Paths That Actually Work
Yes, insurance can cover semaglutide — but only when the right product, diagnosis, and documentation line up. Most people who get denied are asking for the wrong product, missing exact plan criteria, or filing weak paperwork. Fix those three things and your odds improve fast.
Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.
The Quick Decision: What to Do Based on Your Insurance Type
Before anything else — this is the 30-second version. Prices last verified March 2026. Coverage rules and pricing are subject to change.
| Your Situation | Best Medication Path | Coverage Likelihood | Best Next Step |
|---|---|---|---|
| Type 2 diabetes (commercial + many Medicare Part D) | Ozempic or Rybelsus | Strong | Ask your doctor to submit PA for Ozempic or Rybelsus |
| Overweight/obese + heart disease (commercial) | Wegovy injection | Moderate to strong | Request PA specifically for the cardiovascular indication |
| MASH with liver fibrosis (commercial) | Wegovy injection | Varies — newer indication | Confirm plan covers MASH indication; submit PA with hepatology notes |
| Weight loss only (employer/commercial plan) | Wegovy injection or pill | Varies widely — depends on employer | Check formulary first; prepare full documentation package |
| Medicare (weight loss) | Wegovy (Bridge program launches July 1, 2026 at $50/mo) | Limited until July 2026 | Cash-pay now from $149/mo, or wait for July Bridge |
| Medicare (T2D or CV risk) | Ozempic (T2D) or Wegovy (CV indication) | Covered via standard Part D | Ask your doctor to submit PA for the appropriate indication |
| Medicaid | Varies by state | Limited — only 13 states cover for obesity | Check your state's preferred drug list |
| Recently denied | Depends on denial reason | Many denials overturned on appeal | File an appeal — see our denial section below |
The Thing Most Pages Get Wrong About Semaglutide and Insurance
The single most important thing: Insurance companies do not cover "semaglutide." They cover a specific semaglutide product, for a specific approved use, under a specific plan rule.
This sounds obvious, but it trips up nearly everyone. Semaglutide is the active ingredient in four different brand-name medications — each with different FDA-approved uses, different insurance pathways, and different coverage odds. When your doctor writes a prescription for the wrong product, or writes it for the wrong indication, the claim gets denied before it even reaches a human reviewer.
Wegovy Injection
Wegovy injection comes in pen strengths of 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg (the 1.7 mg and 2.4 mg are the maintenance doses).
FDA-approved for:
- Chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition
- Reducing cardiovascular risk (heart attack, stroke, CV death) in adults with established heart disease and obesity or overweight
- Treating MASH with moderate-to-advanced liver fibrosis
- Weight management in children 12+ with obesity
Wegovy Tablets
Wegovy tablets are titrated through 1.5 mg, 4 mg, 9 mg, and 25 mg strengths. FDA-approved December 2025 and available in the US since January 2026.
- Adult chronic weight management (obesity or overweight with at least one weight-related condition)
- Reduction of major cardiovascular events in adults with established cardiovascular disease and overweight/obesity
Ozempic (semaglutide 0.5 mg, 1 mg, or 2 mg injection)
- Type 2 diabetes management (blood sugar control)
- Reducing cardiovascular risk in adults with T2D and heart disease
- Reducing kidney disease progression in adults with T2D and chronic kidney disease
Rybelsus (semaglutide tablets, 3 mg, 7 mg, or 14 mg)
FDA-approved for type 2 diabetes management and reducing risk of cardiovascular events in people with T2D. About 98% of commercial plans cover Rybelsus for type 2 diabetes. Eligible commercially insured patients may pay as little as $25 per fill with the Rybelsus Savings Card. Rybelsus list price is $997.58 per package. It is not approved for weight loss.
Source: NovoMedLink Rybelsus cost & coverage
Why This Matters for You
If you walk into your doctor's office and say "I want semaglutide for weight loss," and your doctor prescribes Ozempic, your insurance will very likely deny the claim — because Ozempic is not approved for weight loss. The fix: ask your doctor about Wegovy specifically. Same active ingredient. But the brand name, the approved indication, and the insurance pathway are completely different.
When Insurance Is Most Likely to Cover Semaglutide
Strong Coverage Odds: Type 2 Diabetes
If you have type 2 diabetes, this is the straightest path. Most commercial plans and many Medicare Part D plans cover Ozempic and Rybelsus for blood sugar management. Prior authorization is usually required, and approval rates tend to be favorable when documentation is solid. Your doctor will need to show an A1C result confirming your diagnosis, document that lifestyle modifications alone are not enough, and in some cases demonstrate that you have tried a first-line medication like metformin.
Moderate Coverage Odds: Heart Disease + Overweight/Obesity
Since Wegovy received FDA approval for reducing cardiovascular risk in adults with established heart disease and obesity or overweight, coverage has expanded. Kaiser Permanente, Elevance Health, and Aetna were among the first major carriers to cover Wegovy specifically for this cardiovascular indication. The key is that your doctor submits the PA under the cardiovascular indication, not the weight-loss indication — same drug, same dose, different approval pathway.
Variable Coverage Odds: Weight Loss Only (Commercial/Employer Plans)
This is the branch where most people get stuck. Whether your commercial insurance covers Wegovy for weight loss depends almost entirely on whether your employer chose a plan that includes anti-obesity medications.
According to KFF's 2025 Employer Health Benefits Survey:
- 43% of firms with 5,000+ workers covered GLP-1 medications for weight loss
- 19% of firms with 200+ workers overall covered weight-loss GLP-1s
- 34% of covering firms required a dietitian, case manager, or lifestyle program as a condition of coverage
What Improves Your Odds
- BMI ≥30, or BMI ≥27 with a documented weight-related condition
- 3–6 months of documented lifestyle modifications
- Previous weight-loss medications tried (if step therapy required)
- Strong letter of medical necessity
What Works Against You
- Your employer specifically excludes anti-obesity drugs
- Weak or incomplete documentation
- Requesting Ozempic instead of Wegovy for weight loss
Want someone to handle the paperwork?
Ro's insurance concierge contacts your insurer directly, identifies the best product path, and handles prior authorization — so you do not spend weeks on hold with your insurance company.
Let Ro check your coverage → $45 to startHard Path: Medicare (But Changing Fast)
Under current federal law, the basic Medicare Part D benefit cannot cover medications prescribed solely for weight loss. This prohibition dates back to 2003.
What Medicare Part D covers today:
- Ozempic and Rybelsus for type 2 diabetes: yes, with prior authorization
- Wegovy for cardiovascular risk reduction in adults with heart disease + obesity/overweight: yes, some Part D plans cover this
- Wegovy or any semaglutide for weight loss alone: no — not through the standard Part D benefit
What is changing:
- July 1, 2026: CMS launches the Medicare GLP-1 Bridge demonstration. Covers Wegovy injection, Wegovy tablets, and Zepbound for eligible weight-management use at a $50/month copay. The Bridge runs July 1–December 31, 2026, and operates outside the normal Part D payment flow — the $50 copay does NOT count toward your Part D TrOOP or the $2,100 out-of-pocket cap.
- January 2027: The BALANCE Model launches in Medicare Part D, providing broader long-term coverage through participating plans.
Sources: CMS BALANCE Model; CMS Medicare Part D policy
If you are on Medicare and want semaglutide for weight loss right now (before July 2026): cash-pay at manufacturer pricing ($149–$349/month depending on product and dose through NovoCare Pharmacy), or wait for the Bridge program.
Limited Path: Medicaid
Medicaid coverage of GLP-1 medications for obesity treatment remains limited and varies dramatically by state. According to KFF, only 13 state Medicaid programs covered GLP-1s for obesity treatment under fee-for-service as of January 2026. Coverage for diabetes and cardiovascular indications is generally required.
Your best move: call your state Medicaid office or check your state's preferred drug list online. Ask specifically about Wegovy for weight management — not just "semaglutide." Source: KFF Medicaid GLP-1 Coverage Tracker, January 2026
How to Get Semaglutide Covered by Insurance in 7 Steps
This is the system. Each step matters. Skip one and you risk a denial that could have been prevented.
Pick the Right Semaglutide Product Before You Do Anything Else
This is where most people go wrong. Match the product to your diagnosis:
If your doctor suggests Ozempic for weight loss, respectfully ask about Wegovy instead. Off-label prescriptions are among the most common causes of preventable denials.
Check Your Formulary and Plan Type
Before your doctor submits anything, find out whether the product is on your plan's drug list (formulary).
How to check:
- 1Log into your insurance portal and search the formulary for the specific product name (Wegovy, Ozempic, etc.)
- 2Call the member services number on your insurance card
- 3Use NovoCare's free coverage checker at novocare.com (works for Wegovy and Ozempic)
- 4Use Ro's free GLP-1 Insurance Coverage Checker at ro.co — it contacts your insurer and provides a personalized coverage report
What to look for:
- Is the product listed at all?
- What tier is it on? (Higher tier = higher copay)
- Is prior authorization required? (For semaglutide, it almost always is)
- Is step therapy required? (You may need to try a cheaper drug first)
- Is there a specialty pharmacy requirement? (Some plans route GLP-1s through designated pharmacies like Accredo)
Ask for the Exact Coverage Criteria — in Writing
This is the step that separates approvals from denials. Call your insurance company and ask these 9 questions:
- 1Is [specific product] on my plan's formulary?
- 2Under which diagnosis is it covered?
- 3Does it require prior authorization?
- 4Does it require step therapy? If so, which medications must I try first?
- 5Are there BMI or comorbidity thresholds?
- 6Does it require participation in a lifestyle or weight management program?
- 7Which pharmacy must fill it?
- 8What is my expected copay or coinsurance?
- 9If denied, what is the deadline to file an appeal?
Red flags during the call:
- "That medication is not in our system" — ask them to search by brand name.
- "Coverage depends on the doctor" — coverage depends on the plan. Ask for written confirmation.
- "You don't need prior authorization" — for semaglutide, this is uncommon. Get it in writing.
Gather the Documents Insurers Actually Want
Here is the documentation checklist. Print this. Give it to your doctor. This is what separates a first-try approval from a preventable denial.
Semaglutide Prior Authorization Documentation Checklist
- Current BMI calculation with height and weight
- Weight history (ideally 12+ months of documented weights)
- Primary diagnosis with ICD-10 code (obesity, T2D, CVD, MASH, etc.)
- List of weight-related comorbidities (hypertension, high cholesterol, sleep apnea, T2D, PCOS, cardiovascular disease, MASH)
- A1C and metabolic lab results (if applicable)
- Cardiovascular history documentation (if using CV indication)
- Documentation of prior weight-loss attempts — diet, exercise, behavioral counseling (3–6 months minimum for many plans)
- Previous weight-loss medications tried, with start/stop dates and outcomes (if step therapy required)
- Letter of medical necessity from prescriber explaining why semaglutide is appropriate for THIS patient
- Confirmation: no personal or family history of medullary thyroid carcinoma (MTC) or MEN 2 syndrome
- Statement that medication will be used as an adjunct to diet and exercise
Win Prior Authorization on the First Try
PA approvals are not random. Here are the three most common semaglutide PA mistakes — and how to avoid every one of them.
Mistake 1: Wrong Product for Wrong Indication
If you want semaglutide for weight loss and your doctor submits a PA for Ozempic, the claim gets denied automatically. The system is literal. Ozempic is not FDA-approved for weight loss.
The fix: Before your appointment, tell your doctor you have researched the insurance pathway and that Wegovy is the appropriate product for a weight-loss indication. Bring this guide if it helps.
Mistake 2: Thin Documentation
A PA form with a diagnosis code, a BMI number, and nothing else will get denied at many plans. Insurers want a complete clinical picture — weight history, comorbidities, lab results, prior weight-loss attempts, and a clear statement of medical necessity.
The fix: Use the documentation checklist from Step 4. Give it to your doctor before they submit. The 20 minutes it takes to gather thorough documentation saves weeks of denial-and-resubmit cycles.
Mistake 3: Generic Medical Necessity Language
"Patient would benefit from weight management medication" is weak. Insurers see thousands of these. It tells them nothing specific about why this patient needs this drug.
The fix: The letter of medical necessity should mirror the insurer's own published criteria language. If the criteria require 'documented participation in a structured weight management program for at least 3 months,' the letter should say exactly that — with dates, program names, and outcomes.
What Your Doctor's PA Submission Should Include (at minimum):
- Current BMI with exact weight and height measurements
- Duration and nature of the weight condition
- All weight-related comorbidities with supporting lab values (A1C, lipid panel, blood pressure)
- Specific prior weight-loss attempts with dates, methods, and outcomes
- Why semaglutide is medically appropriate for this patient specifically
- Why alternative treatments are insufficient or have been tried
- Plan for ongoing monitoring and lifestyle modification support
Know What It Will Cost With and Without Insurance
Prices last verified March 2026 via NovoCare Pharmacy. Pricing subject to change.
| Medication | List Price | With Commercial Insurance + Savings Card | Cash / Self-Pay via NovoCare |
|---|---|---|---|
| Wegovy Injection | $1,349/mo | As low as $25/month | $199/mo for 0.25/0.5 mg (intro pricing); $349/mo for all other doses |
| Wegovy Pill | $1,349/mo | As low as $25/month | $149/mo for 1.5 mg; $149/mo for 4 mg (through 4/15/2026); $299/mo for 9 mg and 25 mg |
| Ozempic | $935–$1,028/mo | As low as $25/month (T2D indication) | $199/mo for 0.25/0.5 mg (intro pricing); $349/mo for 0.25/0.5/1 mg; $499/mo for 2 mg |
| Rybelsus | $997.58/package | As low as $25/fill (T2D indication) | No comparable discount program for off-label weight-loss use |
If You Are Denied: File an Appeal
Getting denied is common. It is also not the end. Many insurance denials are successfully overturned on appeal with stronger documentation. The system is designed to be challenged.
See our complete step-by-step guide: How to Appeal a GLP-1 Denial →
What to Do If Insurance Denies Semaglutide Coverage
First: Read the Denial Reason
Your insurer must provide a written explanation for every denial. This matters because the fix depends entirely on why you were denied:
| Denial Reason | What It Means | What to Do |
|---|---|---|
| Not medically necessary | Insurer says you haven't proven you need it | Strengthen documentation: add comorbidities, lab results, weight history, failed lifestyle attempts |
| Not on formulary | Product isn't on your plan's drug list | Request a formulary exception with a letter of medical necessity |
| Step therapy required | Must try a cheaper medication first | Try the required med (or have your doctor justify an exception if there's a medical reason to skip it) |
| Benefit exclusion | Your employer's plan excludes weight-loss drugs entirely | Request employer add coverage (Novo Nordisk provides a template letter), or use cash-pay options |
| Off-label use | You were prescribed Ozempic for weight loss | Switch the prescription to Wegovy — this is one of the most fixable denials |
| Incomplete documentation | PA submission was missing required information | Resubmit with complete documentation using the checklist above |
| Quantity/dose limit | Prescribed dose exceeds plan limits | Doctor can request a quantity exception with clinical justification |
The 3-Level Appeal Process
You have legal rights here. Use them.
Level 1: Internal Appeal
File within the deadline stated in your denial letter (usually 30–180 days depending on plan type). Your doctor can also request a peer-to-peer review — a direct phone conversation with the insurer's medical director. Peer-to-peer reviews can be one of the more effective paths to a fast resolution.
- A written appeal letter addressing the specific denial reason
- Updated documentation filling any gaps
- Supporting clinical literature if relevant
- Updated lab work if available
Level 2: Second Internal Appeal
If Level 1 fails, most plans allow a second-level review by a different medical director. Bring stronger evidence — additional clinical studies, more detailed medical necessity arguments, and any documentation you did not include the first time.
Level 3: External Independent Review
If both internal appeals fail, you can request an independent external review. A licensed healthcare professional outside your insurance company evaluates your case. This decision is legally binding — if they rule in your favor, your insurer must provide coverage.
- Wegovy Exceptions, Denials, and Appeals Guide
- Sample Letter of Appeal template
- Sample Letter of Medical Necessity
- Sample Letter to HR/Benefits Manager requesting coverage
Available at NovoMedLink PA and appeals resources
Just got denied? Ro's team can help you navigate the appeal.
Ro's clinical team has experience working through insurance denials for semaglutide. They can help identify the denial reason, prepare updated documentation, and explore cash-pay paths if needed.
Real Semaglutide Coverage Criteria From Major Insurers
We pulled actual published prior authorization criteria from major PBMs and insurers so you can see exactly what they require.
Criteria verified March 2026. Insurer policies can change. Always confirm current criteria with your specific plan.
| Payer / PBM | Product | Weight-Loss Criteria | Lifestyle Requirement | Source |
|---|---|---|---|---|
| CVS Caremark | Wegovy | BMI ≥30 (or ≥27 + comorbidity); comorbidity documentation required at lower threshold | Reduced-calorie diet + increased physical activity must be documented | CVS Caremark Wegovy criteria (PDF) |
| Cigna | Weight-loss GLP-1 | BMI thresholds consistent with FDA label; comorbidity documentation required | 3 months of documented behavioral modification and dietary restriction before approval | Cigna published PA criteria |
| UnitedHealthcare | Wegovy | Varies significantly by plan type; some plans cover, others exclude weight-loss meds | Varies by plan; CV and MASH indications may have separate (sometimes more favorable) pathways | UHC formulary documents |
The pattern across all major insurers:
What to Say When You Call Your Insurance Company
The Phone Script
Then ask:
- 1Is this product on my plan's formulary? What tier?
- 2Does it require prior authorization?
- 3Are there step therapy requirements? Which medications must I try first?
- 4What specific clinical criteria does the PA require — BMI threshold, comorbidities, lifestyle documentation?
- 5Is there a required lifestyle program or dietitian visit?
- 6Does the prescription need to go through a specialty pharmacy?
- 7What is my expected copay or coinsurance once approved?
- 8If the PA is denied, what is the deadline to file an appeal?
- 9Can you send me the written prior authorization criteria by mail or email?
The Fastest Path When Insurance Is Uncertain
You have read the steps. You understand the system. But maybe you are looking at all of this and thinking: I do not want to spend weeks calling insurance companies, tracking down criteria, and filing paperwork myself. That is exactly the problem Ro built its insurance concierge to solve.
How Ro's Insurance Concierge Works
Ro is a licensed telehealth platform that prescribes FDA-approved GLP-1 medications and includes a dedicated insurance concierge team.
- 1You complete an online intake (about 15 minutes). A licensed provider reviews your health history and goals.
- 2Labs are ordered if medically necessary. Through Quest Diagnostics.
- 3Ro's insurance concierge contacts your insurer directly. They check your coverage, identify the best product path, and handle prior authorization paperwork on your behalf. This process typically takes about 2–3 weeks.
- 4If approved: You pay your copay. Medication ships to your door or is available for pharmacy pickup.
- 5If denied: The team helps you understand the denial, explores alternatives, and presents cash-pay paths at manufacturer pricing.
- 6Ongoing: Monthly provider check-ins, dose adjustments based on your response and labs, and messaging support.
Who Ro Is Best For
- Commercially insured people who want someone else to handle the prior auth
- People who have been denied and want professional help with the appeal
- Those who value speed and lower administrative friction
- Anyone who wants clinical support (labs, provider oversight) alongside medication
Who Ro Is Not Best For
- Medicaid users — cannot join Ro Body
- Medicare/TRICARE users who need government-plan GLP-1 coverage coordination
- People who already have a clean insurance approval path
- People expecting the membership to include medication cost (it doesn't — billed separately)
What Ro Costs
The honest math worth considering:
If the concierge gets your brand-name medication covered through insurance, that coverage can save you hundreds per month compared to cash-pay pricing. Clinical trials show patients taking Wegovy lost an average of 14.9% of body weight over 68 weeks — roughly 33.7 pounds. (Source: STEP 1 clinical trial, New England Journal of Medicine, 2021)
Your insurance might cover more than you think.
Thousands of people who assumed they would pay out-of-pocket discovered coverage they did not know they had — because someone checked for them.
Let Ro check your coverage and handle the paperwork → $45 to startIs Compounded Semaglutide Covered by Insurance?
Short answer: No.
Compounded semaglutide is not FDA-approved, and no insurance plan covers it. It is cash-pay only.
- The FDA resolved the semaglutide injection shortage in February 2025. With all doses of FDA-approved Wegovy and Ozempic now fully available nationwide, the legal landscape for compounded semaglutide has tightened significantly.
- The FDA has issued warnings about dosing errors with compounded injectable semaglutide and about fraudulent and illegally marketed compounded GLP-1 products.
- With brand-name Wegovy now available at $149/month (pill, lowest dose) or $199/month (pen, intro pricing for lowest doses) through NovoCare Pharmacy, the price gap between compounded and FDA-approved options has narrowed significantly.
Sources: FDA compounded semaglutide alerts; FDA semaglutide shortage resolution, February 2025
What to Expect After Your Insurance Approves Semaglutide
Dosing schedule
Semaglutide starts at a low dose and increases gradually over several months. This titration period reduces side effects. Do not expect to be on the full dose from day one.
Common side effects
Nausea, diarrhea, constipation, and reduced appetite are most common, particularly in the first few weeks and after dose increases. These typically improve over time.
Reauthorization
Many insurance approvals last 6–12 months. When it is time to reauthorize, some plans require proof of at least 5% body weight loss. Keep up with provider visits and document progress.
Savings card stacking
If you have commercial insurance coverage, you can often stack Novo Nordisk's savings card on top of your insurance benefit to bring your monthly copay down to $25 or less.
Free Resources That Can Help You Get Semaglutide Covered
- NovoCare Wegovy Coverage Checker — Free, gives results in minutes, works for any insurance plan
- Ro's Free GLP-1 Insurance Coverage Checker — Contacts your insurer and provides a personalized coverage report
- NovoCare Savings Card — For commercially insured patients, can reduce Wegovy copay to as low as $25/month
- HealthCare.gov Appeal Resources — Explains your legal rights for internal and external appeals
- Novo Nordisk PA and Appeals Toolkit — Sample appeal letters, medical necessity templates, and employer letters
Frequently Asked Questions
How do I find out if semaglutide is covered by my insurance?
Check your plan's formulary online, call member services, or use NovoCare's free coverage checker at novocare.com. Search for the specific product name — Wegovy or Ozempic — not just 'semaglutide.' Ro also offers a free GLP-1 coverage checker that contacts your insurer and provides a personalized report.
Will insurance pay for semaglutide for weight loss?
Some commercial and employer plans cover Wegovy for weight loss with prior authorization. Coverage depends on your specific plan. Medicare's standard Part D benefit does not cover weight-loss-only use, but the $50/month Bridge program starts July 1, 2026. Medicaid coverage varies by state.
Which insurance companies cover semaglutide?
Many large carriers and PBMs — including Blue Cross Blue Shield, UnitedHealthcare, Aetna, Cigna, and Kaiser Permanente — cover some semaglutide products on some plans. But carrier name alone is not enough to determine your coverage. It varies by specific plan, product, and diagnosis. Always verify with your specific policy.
Does semaglutide require prior authorization?
In most cases, yes. Insurers require your doctor to submit documentation proving medical necessity before they will cover semaglutide. This applies to Wegovy, Ozempic, and Rybelsus across most plans.
What is the difference between Wegovy and Ozempic for insurance purposes?
Same active ingredient (semaglutide), but different FDA-approved uses and insurance pathways. Ozempic is approved for type 2 diabetes. Wegovy is approved for weight loss, cardiovascular risk reduction, and MASH. If you want semaglutide covered for weight loss, your doctor must prescribe Wegovy — not Ozempic.
What happens if my insurance denies semaglutide?
Appeal. Many denials are overturned with stronger documentation. Read the denial reason carefully, fix the specific gap, and file a formal internal appeal. If denied again, you can request an external independent review — and that decision is legally binding. Your doctor can also request a peer-to-peer review with the insurer's medical director.
Does Medicare cover semaglutide for weight loss?
Not through the standard Part D benefit under current law. However, the Medicare GLP-1 Bridge program launches July 1, 2026, covering Wegovy injection, Wegovy tablets, and Zepbound for eligible weight-management use at a $50/month copay through December 31, 2026. Medicare currently covers Wegovy for cardiovascular risk reduction (if you have heart disease) and Ozempic for diabetes through standard Part D.
How much does semaglutide cost with insurance?
With commercial insurance approval and the Novo Nordisk savings card, Wegovy or Ozempic can cost as little as $25/month. Without insurance, NovoCare Pharmacy offers Wegovy injection from $199/month (intro dose) and the Wegovy pill from $149/month (lowest dose) as of March 2026.
Is compounded semaglutide covered by insurance?
No. Compounded semaglutide is not FDA-approved and no insurance plan covers it. It is cash-pay only. With brand-name options now available at $149–$199/month through NovoCare Pharmacy, the price gap between compounded and FDA-approved has narrowed significantly.
Can Ro help with semaglutide prior authorization?
Yes. Ro's insurance concierge handles benefits verification and prior authorization as part of its paid Body Program membership. This works best for commercially insured users and FEHB. Medicare and TRICARE users may be able to pay cash through Ro. Medicaid users cannot join Ro Body.
What is the fastest way to check my semaglutide coverage?
Use NovoCare's online coverage checker (free, results in minutes) or Ro's free GLP-1 coverage checker (contacts your insurer directly). Both provide personalized results based on your insurance information.
Your Next Step
You have the information. You know the system. Now pick your path:
If you have commercial insurance and want help navigating coverage:
Ro's insurance concierge checks your specific plan, handles prior authorization, and finds you the best price — whether through insurance or manufacturer pricing. One intake. One team. No phone-tag with insurance reps.
Let Ro check your coverage → $45 to startIf you want to do it yourself:
Print the documentation checklist from Step 4. Schedule an appointment with your doctor. Bring the checklist and the exact criteria from your insurance plan. Make sure they prescribe the right product (Wegovy for weight loss, not Ozempic). Follow up on the PA within a week.
If you were already denied:
Read the denial letter. Identify the reason. File your appeal within the deadline. Request a peer-to-peer review. Use Novo Nordisk's free appeal template from NovoCare.
Not sure which GLP-1 program is right for you?
Our free 60-second matching quiz routes you to the right program based on your insurance type, health profile, and budget — no email required.
Take the 60-second free quiz →Related Guides
Sources
This guide is for informational purposes only and does not constitute medical or insurance advice. Coverage policies change frequently. Always verify current requirements with your insurance provider and consult your healthcare provider for medical decisions. Prices and programs referenced were verified as of March 2026 and are subject to change.
- FDA Wegovy prescribing information (2026)
- CMS BALANCE Model announcement, December 23, 2025
- CMS Medicare Part D policy fact sheet
- NovoCare pricing and coverage tools
- NovoMedLink PA and appeals resources
- KFF 2025 Employer Health Benefits Survey
- KFF Medicaid GLP-1 Coverage Tracker, January 2026
- HealthCare.gov appeal rights
- CVS Caremark Wegovy criteria
- FDA compounded semaglutide alerts
- Ro weight loss pricing and insurance